Rallybio Corporation

RLYB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$13,903$24,494$56,958$175,334
Short-Term Investments$51,608$85,435$112,036$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,330$4,860$10,502$5,535
Total Curr. Assets$67,841$114,789$179,496$180,869
Property Plant & Equip (Net)$267$592$909$511
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$239$30$805
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$267$831$939$1,316
Other Assets$0$0$0$0
Total Assets$68,108$115,620$180,435$182,185
Liabilities
Payables$278$976$1,114$603
Short-Term Debt$154$219$181$0
Tax Payable$0$0$0$0
Deferred Revenue$848$0$0$0
Other Curr. Liab.$4,962$8,068$9,449$5,948
Total Curr. Liab.$6,242$9,263$10,744$6,551
LT Debt$0$173$374$0
Deferred Rev, NC$212$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$32
Total NC Liab.$212$173$374$32
Other Liabilities$0$0$0$0
Cap. Leases$154$392$555$0
Total Liabilities$6,454$9,436$11,118$6,583
Equity
Pref Stock$0$0$0$0
Common Stock$4$4$4$3
Retained Earnings-$293,020-$235,245-$160,681-$94,027
AOCI$68$15-$214$0
Other Equity$354,602$341,410$330,208$269,626
Total Equity$61,654$106,184$169,317$175,602
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$68,108$115,620$180,435$182,185
Net Debt-$13,749-$24,102-$56,403-$175,334